639 related articles for article (PubMed ID: 17583173)
21. Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.
Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
Am J Cardiol; 2007 Aug; 100(4):690-6. PubMed ID: 17697830
[TBL] [Abstract][Full Text] [Related]
22. [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study].
Ertl G; Nitschmann S
Internist (Berl); 2004 Jul; 45(7):835-6. PubMed ID: 15054581
[No Abstract] [Full Text] [Related]
23. Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate.
Delea TE; Stanford R; Hagiwara M; Edelsberg JS; Oster G
Int J Cardiol; 2005 Mar; 99(1):117-24. PubMed ID: 15721509
[TBL] [Abstract][Full Text] [Related]
24. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
[TBL] [Abstract][Full Text] [Related]
25. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
[No Abstract] [Full Text] [Related]
26. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis.
Packer M; Antonopoulos GV; Berlin JA; Chittams J; Konstam MA; Udelson JE
Am Heart J; 2001 Jun; 141(6):899-907. PubMed ID: 11376302
[TBL] [Abstract][Full Text] [Related]
27. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.
Swedberg K; Olsson LG; Charlesworth A; Cleland J; Hanrath P; Komajda M; Metra M; Torp-Pedersen C; Poole-Wilson P
Eur Heart J; 2005 Jul; 26(13):1303-8. PubMed ID: 15767288
[TBL] [Abstract][Full Text] [Related]
28. Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET.
McBride BF; White CM
J Clin Pharmacol; 2005 Jan; 45(1):6-24. PubMed ID: 15601801
[TBL] [Abstract][Full Text] [Related]
29. Carvedilol and metoprolol European trial: do the results merit challenge?
Smith KM
Am J Health Syst Pharm; 2004 Jun; 61(12):1289-93. PubMed ID: 15259762
[No Abstract] [Full Text] [Related]
30. Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.
Remme WJ; Cleland JG; Erhardt L; Spark P; Torp-Pedersen C; Metra M; Komajda M; Moullet C; Lukas MA; Poole-Wilson P; Di Lenarda A; Swedberg K
Eur J Heart Fail; 2007 Nov; 9(11):1128-35. PubMed ID: 17716943
[TBL] [Abstract][Full Text] [Related]
31. [A fairer comparison between carvedilol and metoprolol is still to be done].
Johnsson G; Aberg J
Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
[No Abstract] [Full Text] [Related]
32. In heart failure, all beta-blockers are not necessarily equal.
Tang WH; Militello M; Francis GS
Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
[TBL] [Abstract][Full Text] [Related]
33. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lubsen J; Lutiger B; Metra M; Remme WJ; Torp-Pedersen C; Scherhag A; Skene A;
Lancet; 2003 Jul; 362(9377):7-13. PubMed ID: 12853193
[TBL] [Abstract][Full Text] [Related]
34. Carvedilol: use in chronic heart failure.
Doughty RN; White HD
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
[TBL] [Abstract][Full Text] [Related]
35. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
Fowler MB
Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
[TBL] [Abstract][Full Text] [Related]
36. [Beta-blocking drugs indicated in patients with heart failure].
Voors AA; van Gilst WH; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2457-9. PubMed ID: 14708208
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of the effects of carvedilol versus metoprolol on all-cause mortality and hospitalizations in patients with heart failure.
Briasoulis A; Palla M; Afonso L
Am J Cardiol; 2015 Apr; 115(8):1111-5. PubMed ID: 25708861
[TBL] [Abstract][Full Text] [Related]
38. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.
Metra M; Torp-Pedersen C; Swedberg K; Cleland JG; Di Lenarda A; Komajda M; Remme WJ; Lutiger B; Scherhag A; Lukas MA; Charlesworth A; Poole-Wilson PA
Eur Heart J; 2005 Nov; 26(21):2259-68. PubMed ID: 16040619
[TBL] [Abstract][Full Text] [Related]
39. [Beta-adrenolytics in heart failure--are they all really equal?].
Filipiak KJ; Opolski G
Przegl Lek; 2005; 62 Suppl 2():39-42. PubMed ID: 16623117
[TBL] [Abstract][Full Text] [Related]
40. Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metoprolol European Trial (COMET) trial.
Olsson LG; Swedberg K; Cleland JG; Spark PA; Komajda M; Metra M; Torp-Pedersen C; Remme WJ; Scherhag A; Poole-Wilson P;
Eur J Heart Fail; 2007 Aug; 9(8):795-801. PubMed ID: 17693380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
